Synagis palivizumab 50mg/0.5 mL Single-Dose VialSynagis palivizumab 50mg 0. 5 mL Single Dose Vial is a highly effective medication used for the prevention of serious respiratory tract infections caused by the respiratory syncytial virus (RSV) in infants and children. RSV is a common virus that can lead to severe respiratory infections in young children, particularly those with weakened immune systems. Synagis palivizumab, with its active ingredient 50mg of palivizumab, is administered by injection

Packaged as a pair

Ships directly from manufacturer - Can take up to 7-10 business days to ship

Suitable for glove compartment

45% sodium caprylate

ColoScreen Lab Pack (Bulk 1000) is designed to provide you with a high quality

giving you the same soothing experience  you know from Vicks

- Single-Use (Disposable)

Symptoms may include hives

2 The effectiveness of the ORTHOVISC treatment is partially based on the product’s delivery of one of the highest concentrations of HA (15 mg/mL) currently available in a multi-injection treatment

All of these have been added to help give baby strong bones and teeth plus support growth and development

catering to specialized testing requirements

Versatility: An indispensable tool for hospitals